Angiogenesis in benign and malignant thyroid disease.
BACKGROUND
Angiogenesis has been recognized as an important process contributing to the pathophysiology of many benign and malignant diseases. It is not surprising, therefore, that this complex process is proving to be an important regulator of both benign and malignant disease processes in the thyroid gland. This paper will review the general principles of angiogenesis and lymphangiogenesis, as well as the importance of the balance between angiogenic stimulators and inhibitors in the normal thyroid gland. We will also review how this balance is disturbed in benign and malignant thyroid conditions. Finally, we will address the role manipulation of this process may play in the development of novel treatment strategies for diseases of the thyroid.


OBJECTIVE
To review the literature concerning the role of angiogenesis in the thyroid gland.


CONCLUSIONS
Angiogenesis is an important process which has been shown to be involved in the pathophysiology of benign and malignant diseases of the thyroid gland. Manipulation of this process holds great promise for the development of novel treatments for these disorders. As the mechanisms regulating angiogenesis in the thyroid become increasingly clear, researchers will come ever closer to turning this promise into clinical reality.
Mitchell
Jamie C
JC
Department of Surgery, Section of Endocrine Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Parangi
Sareh
S
D000818:Animals; D006801:Humans; D009389:Neovascularization, Pathologic; D013959:Thyroid Diseases / Q000473:pathology* / Q000503:physiopathology*; D013961:Thyroid Gland / Q000098:blood supply* / Q000473:pathology*